Pediatric Rheumatology

Article	Citations
Predictors of fibrogenesis in children with JIA: a single-center pilot study	47
Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial	40
Algorithmic approach in the diagnosis of pediatric uveitis	38
Peripheral blood regulatory T cells and disease activity, quality of life, and outcomes in children with juvenile idiopathic arthritis	33
Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience	33
Serositis as an indicator of poor prognosis in pediatric systemic lupus erythematosus	31
The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource	27
Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers’ perspectives	25
Clinical features, treatment, and outcomes of celiac-associated arthritis: a retrospective cohort study	25
Musculoskeletal symptoms and their impact on health-related quality of life in chronic nonbacterial osteomyelitis patients	24
Experiences of sexual and reproductive health screening and counseling in the clinical setting among adolescents and young adults with rheumatic disease	24
Juvenile dermatomyositis: association between nail fold capillary end row loop– area under the curve– and disease damage indicators	23
Efficacy and safety of telitacicept in children with IgA vasculitis and IgA vasculitis nephritis: a single-center retrospective study	23
The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis	23
Three cases of autoinflammatory disease with novel NLRC4 mutations, and the first mutation reported in the CARD domain of NLRC4 associated with autoinflammatory infantile enterocolitis (AIFEC)	21
Neurological involvement in children with familial Mediterranean fever: a systematic review	20
Pediatric immune-mediated necrotizing myopathy with anti-SRP antibodies targeting 19, 68, and 72 kda subunits	20
A randomized controlled educational study to evaluate an e-learning module to teach the physical examination of the temporomandibular joint in juvenile idiopathic arthritis	20
Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the “comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS” (S	19
The clinical relevance of different antiphospholipid antibody profiles in pediatric rheumatology patients	19
Investigating the association between SARS-CoV-2 infection, COVID-19 vaccination, and autoimmune diseases in a pediatric population: a comprehensive analysis	19
A roadmap for navigating child health research data sharing across Canada and beyond – building on UCAN CAN-DU	19
Clinical correlates and predictors of thrombocytopenia in childhood-onset systemic lupus erythematosus: a retrospective cohort study	18
Meningococcal ACWY conjugate vaccine immunogenicity in adolescents with primary or secondary immune deficiencies, a prospective observational cohort study	18
Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort	17

Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals	16
Relationship of regional ultraviolet index data with rash and systemic disease activity in youth with childhood-onset systemic lupus: results from the Childhood Arthritis and Rheumatology Research All	16
Two- and 3-year outcomes of the childhood arthritis and rheumatology research alliance FiRst Line Options for sJIA Treatment (FROST) trial	16
Cervical spine arthritis as initial manifestation in Juvenile Idiopathic Arthritis: a multicenter retrospective study	16
Frequency of remission achievement in the pre-treat-to-target decade in juvenile idiopathic arthritis	16
Proceedings of the 29th European Paediatric Rheumatology Congress	16
Natural autoimmunity in oligoarticular juvenile idiopathic arthritis	16
Exploring paediatric rheumatology care: a ten-year retrospective analysis of the patient population in Ghana	16
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study	15
Cytokines in saliva, serum, and temporomandibular joint synovial fluid in children with juvenile idiopathic arthritis: An explorative cross-sectional study	15
Serum bile salt-stimulated lipase levels associates with systemic inflammation and declines with effect of treatment in juvenile idiopathic arthritis	15
How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience	14
Breaking the storm: canakinumab as salvage therapy for refractory macrophage activation syndrome in pediatric systemic lupus erythematosus—a case report	14
Identification of a variant in NLRP3 gene in a patient with Muckle-Wells syndrome: a case report and review of literature	14
Correction: PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?	14
Body mass index is associated with health-related quality of life and disease characteristics in young adults with juvenile idiopathic arthritis	14
Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis	14
14-month-old female with anti-MDA5 juvenile dermatomyositis complicated by liver disease: a case report	13
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis	13
Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry	13
Exploring the clinical profiles and management of juvenile dermatomyositis in Africa: a survey of African rheumatology care providers	13
Developing consensus outcome measures in juvenile systemic sclerosis: a global survey of pediatric rheumatologists and literature review	12
Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases	12
Long noncoding RNAs (CTC-471J1.2, NeST) as epigenetic risk factors of active juvenile lupus nephritis: a case-control study	12
Longitudinal assessment of preparation for care transition among adolescents and young adults with rheumatologic disease: a single-center pilot study	12
Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report	12
Feasibility of quantitative sensory testing in juvenile idiopathic arthritis	12
An iceberg I can’t handle: a qualitative inquiry on perceptions towards paediatric rheumatology among healthcare workers in Kenya	12
Clinical features, triggers, and risk factors of severe gastrointestinal involvement in anti-NXP2-positive juvenile dermatomyositis: a retrospective cohort study	11
Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort	11
Exploring physical activity patterns in adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos Syndrome	11
Maternal and infant outcomes of pregnancy associated with anti-SSA/RO antibodies: a systematic review and meta-analysis	11
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report	11
Circulating prolactin level in Juvenile Systemic Lupus Erythematosus and its correlation with disease activity: a case control study	11
Differences between leukemic arthritis and juvenile idiopathic arthritis	11
Enhancing the precision of clinical assessment in juvenile idiopathic arthritis through the JADAS	10
Tapering of biological treatment in autoinflammatory diseases: a scoping review	10
Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance	10
A qualitative evaluation of the specific carbohydrate diet for juvenile idiopathic arthritis based on children’s and parents’ experiences	10
Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis	10
Outcomes of arthrocentesis and arthroscopy in the management of TMJ involvement in juvenile idiopathic arthritis: a retrospective analysis	10
Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases	10
Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms	10
Critical care outcomes of hemophagocytic lymphohistiocytosis in children: a single centre retrospective observational study	10
A novel PRKDC mutation caused B lymphocytes V(D)J rearrangement disorder in the SLE-DAH like symptoms patient	10
Epstein–Barr Virus encephalitis associated hemophagocytic lymphohistiocytosis in childhood-onset systemic lupus erythematosus: a case-based review	10
Management of childhood-onset systemic lupus erythematosus (cSLE) over the last two decades in Spain	9
A virtual pediatric rheumatology teaching initiative for physicians in Somaliland	9
Structural ultrasound of joints and tendons in healthy children: development of normative data	9
Kawasaki disease in Kenya and review of the African literature	9

Scurvy masquerading as IgA vasculitis	9
Chronic non-bacterial osteomyelitis in children- five-year standardized follow-up of a prospective observational cohort in the pre-biological era	9
Identifying outcome measures for clinical trials in juvenile idiopathic arthritis associated uveitis for the MIWGUC proposal: a scoping review to create domains from existing outcome measures	9
Hypertension as a prominent manifestation secondary to renal artery lesions in pediatric Behcet’s disease	9
Axial involvement in enthesitis-related arthritis: results from a single-center cohort	8
Feasibility of applying infrared thermal imaging for home monitoring of arthritis in children	8
Characterizing lupus in African American children in Southern United States	8
ANCA-negative eosinophilic granulomatosis with polyangiitis in a girl misdiagnosed as asthma and pulmonary tuberculosis	8
Correction: Transition readiness among finnish adolescents with juvenile idiopathic arthritis	8
High rheumatoid factor does not diminish efficacy of TNF inhibitors in seropositive JIA	8
Janus kinase inhibitors are of limited use in refractory JIA-associated uveitis: retrospective data from a tertiary uveitis center	8
Assay for interferon gamma release as a novel marker in pediatric patients with systemic lupus erythematosus	8
Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research	8
Systemic steroidophobia scale for pediatric rheumatology (SSS-PR): development and validation of a novel psychometric tool measuring clinician steroidophobia	8
Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis	8
Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination	8
Unmet social needs in pediatric rheumatic disease: a study of disparities	8
Towards a histological diagnosis of childhood small vessel CNS vasculitis	8
Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study	8
Depression and anxiety in childhood-onset systemic lupus erythematosus: prevalence, associated factors, and impact on quality of life and family	8
Panniculitis with late onset enthesitis-related arthritis: a case report	8
Whole-exome sequencing analysis identifies novel variants associated with Kawasaki disease susceptibility	8
MicroRNA-27a-3p enhances the inflammatory phenotype of Juvenile Idiopathic Arthritis fibroblast-like synoviocytes	8
Correction: Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases	8
Bone health and physical activity in adolescents with juvenile idiopathic arthritis: a cross-sectional case-control study	8
High prevalence of sacroiliitis and early structural changes in the sacroiliac joint in children with enthesitis-related arthritis: findings from a tertiary centre in Hong Kong	8
Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe	7
Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series	7
What have we learned from long-term studies in juvenile idiopathic arthritis? – Prediction, classification, transition.	7
Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study	7
Association of Mediterranean diet adherence with familial Mediterranean fever severity in a Lebanese cohort	7
Systemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study	7
“I’d like more options!”: Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritis	7
Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data	7
Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study	7
Pain-coping scale for children and their parents: a cross-sectional study in children with musculoskeletal pain	7
Kawasaki disease with an asymptomatic reversible splenial lesion	7
Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors	7
Vaccination coverage, immune responses, and clinical characteristics in children with PFAPA syndrome: a monocentric prospective study	7
Camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome masquerading as juvenile idiopathic arthritis: a case series with a novel PRG4 variant and emphasis on bone health	7
Clinical utility of CBC-Derived inflammatory markers for predicting IVIG resistance: findings from a Korean infant Kawasaki disease cohort	7
Objective evaluation of hand physiotherapy in juvenile systemic sclerosis using the MediTutor robotic glove	7
Bacterial infection in patients with juvenile systemic lupus erythematosus and fever	7
Nailfold videocapillaroscopy in patients with deficiency of adenosine deaminase 2 (DADA2): a case-control study	7
Effect of exercise training on heath, quality of life, exercise capacity in juvenile idiopathic arthritis: a meta-analysis of randomized controlled trials	7
Vaccination coverage and serological follow-up in children with rheumatologic diseases: a retrospective single-centre study	7
Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry	7
Musculoskeletal and nail ultrasound findings in children with psoriasis: a case-control study	7
Symptom course of PFAPA syndrome	7
Overlap syndrome in a 12-year-old girl with systemic lupus erythematosus and anti-oj antibody-positive polymyositis: a case report	7
Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort	7
Prevalence of spine pain among Tunisian children and adolescents and related factors	7
Markerless gait analysis for children and adolescents with juvenile idiopathic arthritis using a machine learning pipeline	7
Accuracy and adequacy of photoprotection in pediatric systemic lupus erythematosus patients, and the effect of education on photoprotection: a prospective study	7
A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature	7
An updated overview of Juvenile systemic sclerosis in a French cohort	7
Unveiling the uncommon: diagnostic journey of camurati-engelmann disease in a pediatric patient	7
Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease	7
Paediatric autoimmune diseases with ELANE mutations associated with neutropenia	7
Synchronous disease onset and flares in siblings with PFAPA	6
Proceedings of the 2024 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting	6
Correction: Engaging patients and parents to improve mental health intervention for youth with rheumatological disease	6
Still’s disease: bridging the gap between guidelines and clinical practice	6
Currently recommended skin scores correlate highly in the assessment of patients with Juvenile Dermatomyositis (JDM)	6
The relationships of kinesiophobia and physical function and physical activity level in juvenile idiopathic arthritis	6
Children’s experiences of a support program during their first year with juvenile idiopathic arthritis	6
Clinical characteristics and prognosis of interstitial lung disease in systemic juvenile idiopathic arthritis: a two-center retrospective observational cohort study	6
Discordant phenotype caused by TREX1 variant in siblings with Aicardi-Goutières syndrome	6
A novel frameshift variant in the ADA2 gene of a patient with a neurological phenotype: a case report	6
Early intensification versus step-up biologic strategies in systemic juvenile idiopathic arthritis: a Bayesian network meta-analysis of remission and safety outcomes	6
Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity	6
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis	6
A mixed-method systematic review evaluating interventions in paediatric rheumatology to address caregiver support and well-being	6
Aquaporin-4 IgG antibodies: predictors of positivity and their relationship with neuropsychiatric disorders and white matter lesions in Juvenile systemic lupus erythematosus	6
The effect of TNF treatment uptake on incident hospital admission in Western Australia	6
A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children wit	6
Th17/1 and ex-Th17 cells are detected in patients with polyarticular juvenile arthritis and increase following treatment	6
Juvenile diabetes and systemic sclerosis: just a coincidence?	6
Novel multiple Z-score models for detection of coronary artery dilation: application in Kawasaki disease	6
Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype	6

C-reactive protein to high density lipoprotein cholesterol ratio for predicting coronary artery lesions, and intravenous immunoglobulin resistance in Kawasaki disease	6
Juvenile dermatomyositis: new insights into pathogenesis and clinical applications	6
Impact of psychosocial status on sleep quality in adolescents with childhood-onset systemic lupus erythematosus	6
Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis	6
Exploring pediatric onset Still’s disease patient journey and parental perceptions in Türkiye through a survey	6
Kawasaki disease in neonates: a case report and literature review	5
Can fitness testing promote physical activity in adolescents with juvenile idiopathic arthritis?	5
Correction: Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study	5
α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis	5
The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA	5
Clinical features of Kawasaki disease initially mimicking retropharyngeal abscess: a retrospective analysis	5
Monoarticular juvenile idiopathic arthritis as a distinct clinical entity A proof-of-concept study	5
The 4th NextGen therapies of SJIA and MAS, part 4: it is time for IL-18 based trials in systemic juvenile idiopathic arthritis?	5
Childhood-onset Takayasu arteritis: clinical presentation, challenges and disease course	5
Muscle mass, strength, and sarcopenia in juvenile idiopathic arthritis: a scoping review	5
Revising the WHO Essential Medicines List for paediatric rheumatology update	5
Heart rate variability (HRV) in juvenile fibromyalgia: a preliminary study	5
Touraine-Solente-Gole syndrome: pathogenic variant in SLCO2A1 presented with polyarthralgia and digital clubbing	5
Neutrophil activation in juvenile dermatomyositis: associations with muscle function and disease progression	5
Increased vascular deposition of oxidized LDL in untreated juvenile dermatomyositis	5
A tale of two regions: comparing clinical features and outcomes in pediatric enthesitis-related arthritis	5
International multidisciplinary consensus on the definition and clinical approach for monogenic inflammatory immune dysregulation disorders	5
Longitudinal follow-up of mixed connective tissue disease and overlapping autoimmune diseases of childhood onset in the Afro-descendant population of the French West Indies	5
A narrative review of the literature on illness uncertainty in hypermobile ehlers-danlos syndrome: implications for research and clinical practice	5
Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study	5
The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study	5
Impact of anakinra use on clinical outcomes in children with moderate or severe multisystem inflammatory syndrome in children: a propensity score matched retrospective cohort study	5
Clinical observations on infliximab treatment of infantile onset Takayasu arteritis	5
Lymphocyte apoptosis and its association with the inflammatory markers and disease severity in juvenile-onset systemic lupus erythematosus patients	5
Urinary ALCAM signatures define renal activity and therapeutic response in juvenile lupus nephritis	5
“Online survey of COVID-19 immunization and infection in patients with systemic juvenile idiopathic arthritis and adult-onset still’s disease.”	5
Unmet needs and research gaps in Still’s disease across ages: proceedings from a pediatric and adult joint expert panel	4
Epidemiology and outcomes of non-infectious paediatric uveitis in the French Caribbean: a 15-year cohort study from a high-income health system in Martinique	4
Association of FKBP4 gene polymorphisms with glucocorticoid efficacy in pediatric systemic lupus erythematosus	4
New avenues in childhood vasculitis	4
Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy	4
Resilience and its associations in children with Systemic Lupus Erythematosus and Juvenile Idiopathic Arthritis	4
Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience	4
The utility of miR-16, miR-146a and miR-155 in serum and urine for juvenile idiopathic arthritis diagnostics and monitoring	4
Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry	4
Perspectives and experiences of parents of children with juvenile dermatomyositis: a semi-structured interview study	4
Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata	4
Reverse complete heart block using transcutaneous pacing and repeated plasmapheresis in a neonate with lupus: a case report	4
Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease	4
Proceedings from the 4th NextGen Therapies for SJIA and MAS virtual symposium held February 13–14, 2022	4
Resource utilization and costs of transitioning from pediatric to adult care for patients with chronic autoinflammatory and autoimmune disorders	4
Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices	4
Treat-to-target strategies for the management of familial Mediterranean Fever in children	4
Provider assessment of the temporomandibular joint in Juvenile idiopathic arthritis: a retrospective analysis from the CARRA database	4
Bridging gaps: a qualitative inquiry on improving paediatric rheumatology care among healthcare workers in Kenya	4
Causal relationship between serum metabolites and juvenile idiopathic arthritis: a mendelian randomization study	4
Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: a systematic search and review	4
Kawasaki disease complicated by peripheral artery thrombosis: a case report and literature review	4
Juvenile eosinophilic fasciitis: a single center case series	4
Colchicine treatment can be discontinued in a selected group of pediatric FMF patients	4
Clinical outcomes of giant coronary aneurysms in South Asian children with Kawasaki disease	4
Mental health screening in pediatric rheumatology: a feasibility study	4
Efficacy of mycophenolate mofetil for the maintenance therapy of anti-AQP4 antibody-positive NMOSD complying with probable sjögren’s disease in a 2-year-old girl: a case report	4
A Chinese child with both systemic lupus erythematosus coexisting with neuromyelitis optica spectrum disorder: a case report	4
Clinical profile and long-term outcomes of pediatric-onset Takayasu’s arteritis: data from a mexican national referral center	4
Juvenile Sjögren disease: time for age-specific classification criteria	4
Childhood-onset hypocomplementaemic urticarial vasculitis in France: phenotypic and genotypic diversity in 10 children	4
Clinical characteristics and risk factors of coronary artery lesions in chinese pediatric Takayasu arteritis patients: a retrospective study	4
Defining a therapeutic range for adalimumab serum concentrations in the management of pediatric noninfectious uveitis, a step towards personalized treatment	4
A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list	4
Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates	4
Aicardi-Goutières syndrome type 6: report of ADAR variant and clinical outcome after ruxolitinib treatment in the neonatal period	4
Profiling the peripheral immune response to ex vivo TNF stimulation in untreated juvenile idiopathic arthritis using single cell RNA sequencing	3
Two phenotypes of chronic recurrent multifocal osteomyelitis with different patterns of bone involvement	3
Leveraging the PEDSnet clinical research network and electronic health record data to enhance efficiency of trial enrollment for a rare pediatric rheumatic disease	3
Juvenile idiopathic recurrent parotitis (JIRP) treated with short course steroids, a case series study and one decade follow up for potential autoimmune disorder	3
FDG-PET/CT as a useful tool for disease activity assessment in large vessel vasculitis in childhood	3
Expert collaborative evidence-based consensus for childhood lupus nephritis diagnosis and treatment: unifying clinical approach in Saudi Arabia	3
Epidemiology and comorbidity of juvenile idiopathic arthritis in Poland– a nationwide study	3
Mortality in children and adolescents with autoimmune inflammatory rheumatic diseases admitted to the pediatric intensive care unit	3
Effectiveness and safety of canakinumab in cryopyrin-associated periodic syndrome: a retrospective study in China	3
Factors that influence school attendance and participation in children and adolescents with juvenile idiopathic arthritis - a systematic review of the literature	3
“Why did you choose that score?” – Associations between patient global assessment scores and mental health symptoms in patients with juvenile idiopathic arthritis and systemic lupus erythematosus	3
Serum elafin levels in patients with IgA vasculitis: a prospective case-control study	3
C1-C2 subluxation in enthesitis-related arthritis: two case reports and literature review of ten cases	3
Increasing and maintaining rates of standardized depression screening in youth with childhood-onset systemic lupus erythematosus in a pediatric rheumatology clinic	3
Antibodies to histone in the pediatric population: a retrospective chart review	3
Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): a discrete group of patients	3
The clinical features and outcome of Kawasaki disease combined with G6PD deficiency	3
Increase in stress contributes to impaired jaw function in juvenile idiopathic arthritis: a two-year prospective study	3
Mere coincidence or an association? Case of juvenile idiopathic arthritis in a patient with Klinefelter syndrome	3
Methods for developing and validating outcome measures in paediatric rheumatology	3
Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study	3
Influenza knowledge and barriers to vaccination in immunosuppressed patients in the pediatric rheumatology clinic	3
Pediatric-onset limited ANCA-associated vasculitis arising during pre-existing chronic recurrent multifocal osteomyelitis	3
Juvenile dermatomyositis in Oman: clinical patterns and disease trajectory from a National cohort	3
Identifying circRNA-associated-ceRNA networks in juvenile spondyloarthropathies patients	3
Retropharyngeal abscess-like as an atypical presentation of Kawasaki disease: a case report and literature review	3
Immune checkpoint inhibitors and the pediatric rheumatologist: a pediatric needs assessment	3
Strategic use of levofolinic acid for methotrexate-induced side effects in juvenile idiopathic arthritis: a prospective observational study	3